Obese women may have increased risk of oral contraceptive failure
Obese women may have an increased risk of oral contraceptive failure.
According to researchers from the United States, “Studies have suggested that obesity is associated with an increased risk for oral contraceptive (OC) failure. We conducted a case-cohort study in South Carolina to examine the association between body mass index (BMI) and OC failure by using population-based data sources.”
“Our cohort sample from the source population consists of 205 women who reported using OCs to prevent pregnancy on the 1999 Behavioral Risk Factor Surveillance System survey,” stated L.R. Brunner Huber and colleagues of the University of North Carolina at Charlotte. “The 153 women who reported using OCs at the time of conception on the 2000 Pregnancy Risk Assessment Monitoring System survey represent the case sample that arose from the source population. Logistic regression was used to obtain odds ratios (ORs) and 95% confidence intervals (CIS).”
The investigators reported, “In unadjusted models with normal BMI (20 to 24.9 kg/m2) as the comparison, greater BMI was associated significantly with OC failure (overweight [25 to 29.9 kg/m2], OR=2.54; 95% CI, 1.18-5.50; and obese [{{>=}}30 kg/m2], OR=2.82; 95% CI, 1.05-7.58). After adjustment for education, income, and race/ethnicity, associations were attenuated and no longer statistically significant.”
“In this heterogeneous population, we found a suggestion that overweight and obese women may be at increased risk for OC failure,” concluded the study group. “However, long-term prospective studies are needed to study this association in diverse populations.”
Brunner Huber and colleagues published their study in Annals of Epidemiology (Body mass index and risk for oral contraceptive failure: A case-cohort study in South Carolina. Ann Epidemiol, 2006;16(8):637-643).
For additional information, contact L.R. Brunner Huber, The University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC 28223-0001, USA; E-mail: .(JavaScript must be enabled to view this email address).
Revision date: June 11, 2011
Last revised: by Andrew G. Epstein, M.D.